The use, cultivation, sale and distribution of cannabis is illegal in France under the United Nations international treaty known as the Single Convention on Narcotic Drugs of 1961. However, the use cultivation, sale and distribution of hemp is perfectly legal in the country. Cannabis qualifies as hemp as long as the psychoactive cannabinoid, Tetrahydrocannabinol (THC), content tests below 0.2 percent.
A French entrepreneurial team of three, lead by Antonin Cohen, has found a way to introduce the medical benefits of cannabidiol (CBD) oil by way of vaporizer pens. The electronic vaporizers, called KanaVape (pictured below), are set to be released this month. Each one will contain 5 percent CBD, and no THC.
Lead developer, Cohen (pictured below), is a medical marijuana advocate responsible for founding a medical cannabis association called L’Union Francophone pour les Cannabinoïdes en Médecine, or in English, The Francophone Union for Cannabinoid Medicines. This association was established in 2008, to promote safe access for medical marijuana patients. The associate also aims to educate French journalists, physicians, patients and non-patient citizens of the country because most studies available are written in English, and therefor many people in France just do not have all of the facts about cannabis. The French government and prohibitionists have provided the public with fear propaganda similar to that of the Reefer-Madness campaign in the United States.
KanaVape is being marketed as, “providing a unique cannabinoid experience.” The group is confident that they will not face any legal problems in France because there is no THC in the product. KanaVape will soon be released in France, and other countries throughout Europe.
All plants used to make the cannabidiol concentrate in KanaVape will be grown only on farms Czech Republic, France and Spain that do not use chemicals or pesticides to treat the crops. This way, all products remain environmentally-friendly, and safe for human use.
photo credit: Vice